Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Nebivolol hydrochloride

🥰Excellent
Catalog No. T0154Cas No. 152520-56-4
Alias R-65824, R 065824 hydrochloride, Nebivolol HCl

Nebivolol hydrochloride (R 065824 hydrochloride) is a cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.

Nebivolol hydrochloride

Nebivolol hydrochloride

🥰Excellent
Purity: 100%
Catalog No. T0154Alias R-65824, R 065824 hydrochloride, Nebivolol HClCas No. 152520-56-4
Nebivolol hydrochloride (R 065824 hydrochloride) is a cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.
Pack SizePriceAvailabilityQuantity
10 mg$43In Stock
25 mg$63In Stock
50 mg$97In Stock
100 mg$166In Stock
200 mg$282In Stock
500 mg$488In Stock
1 mL x 10 mM (in DMSO)$38In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Nebivolol hydrochloride"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Nebivolol hydrochloride (R 065824 hydrochloride) is a cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.
Targets&IC50
β1-adrenoceptor:0.8 nM
In vitro
Nebivolol treatment of rats with myocardial infarction lowered mean blood pressure by a small amount. Nebivolol reduced myocardial apoptosis in rats with myocardial infarction when administered intravenously for 10 minutes followed by oral administration.
In vivo
Nebivolol reduced the proliferation of coronary smooth muscle cells (haCSMCs) and endothelial cells (haECs) in a concentration- and time-dependent manner.Nebivolol acted with high affinity and selectivity at the beta 1-adrenergic receptor site in the preparation of rabbit lung membranes.Nebivolol treatment of haCSMCs for 7 days significantly inhibited cell proliferation (IC50 ~ 10 μM). Nebivolol treated haCSMCs for 7 days, significantly inhibited cell proliferation (IC50: 6.1 μM). nebivolol treated haCSMCs for 48 hours, the apoptosis rate was 23%, and reduced the number of S-phase cells.
Cell Research
Cells are exposed to different concentrations of Nebivolol (10-7~10-5 M) for 1, 2, 4, 7 and 14 days. Cell proliferation is analyzed by bromodeoxyuridine (BrdU) incorporation, and cell apoptosis is detected by PI or annexin V staining.(Only for Reference)
AliasR-65824, R 065824 hydrochloride, Nebivolol HCl
Chemical Properties
Molecular Weight441.9
FormulaC22H25F2NO4·HCl
Cas No.152520-56-4
SmilesCl.OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 4.4 mg/mL (10 mM)
DMSO: 60 mg/mL (135.78 mM), Sonication is recommended.
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.2630 mL11.3148 mL22.6296 mL113.1478 mL
5 mM0.4526 mL2.2630 mL4.5259 mL22.6296 mL
10 mM0.2263 mL1.1315 mL2.2630 mL11.3148 mL
DMSO
1mg5mg10mg50mg
20 mM0.1131 mL0.5657 mL1.1315 mL5.6574 mL
50 mM0.0453 mL0.2263 mL0.4526 mL2.2630 mL
100 mM0.0226 mL0.1131 mL0.2263 mL1.1315 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Nebivolol hydrochloride | purchase Nebivolol hydrochloride | Nebivolol hydrochloride cost | order Nebivolol hydrochloride | Nebivolol hydrochloride chemical structure | Nebivolol hydrochloride in vivo | Nebivolol hydrochloride in vitro | Nebivolol hydrochloride formula | Nebivolol hydrochloride molecular weight